Mona M. Shangold — Endo Lab

article 1999

A new clinical option for hormone replacement therapy in women with secondary amenorrhea: Effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologic features and withdrawal bleeding

·doi:10.1016/s0002-9378(99)70147-x

ObjectiveThe objective of this study was to evaluate the safety and efficacy of 2 doses of a transvaginal polycarbophil-based progesterone gel (4% and 8%) in hormone replacement therapy.Study designThis multicenter, randomized, parallel-gro…

article 1991

Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea

·doi:10.1016/s0015-0282(16)54714-1

ObjectiveTo compare two dosages of oral micronized progesterone (P) and placebo for withdrawal bleeding and side effects.DesignProspective, randomized, double-blind.SettingAcademic institution.ParticipantsOut of 190 screened with oligomenor…

article 1984

Menstrual Disturbances in the Athlete

·doi:10.1016/s0095-4543(21)01171-4

Women should be encouraged to exercise. Those who develop menstrual problems should be thoroughly evaluated to detect any serious causes and should be treated to prevent any serious results. The importance of exercise in the lifestyle of fe…

article 1976

Plasma Prostaglandin F2 Levels in Dysmenorrheic Women

·doi:10.1016/s0015-0282(16)42135-7

Plasma prostaglandin F 2-alpha (PGF 2-alpha) concentrations were compared in nine ovulatory dysmenorrheic women, one dysmenorrheic oral contraceptive user, and two nondysmenorrheic control subjects, in an effort to demonstrate a relationshi…